Filtering

Page: () 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 182 ()
N12: Microscopic colitis: struggling with an invisible, disabling disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Pihl Lesnovska*1, A. Munch1, H. Hjortswang1

1University Hospital of Linköping, Gastroenterology and Hepatology, Linköping, Sweden

N13: Quality of life among patients with IBD on biological treatment: does it matter if they are in remission?

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Edelbo*1, M. Hjerrild1, P. Bager1

1Aarhus University Hospital, Hepatology and Gastroenterology, Aarhus, Denmark

N14: Professional profile of nurses working with inflammatory bowel disease in Brazil

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Barros*1, R. de Aguiar Alencar2, R. Saad-Hossne3, L. Yukie Sassaki1

1São Paulo State University (Unesp), Medical School, Department of Internal Medicine, Botucatu, Brazil, 2São Paulo State University (Unesp), Medical School, Department of Nursing, Botucatu, Brazil, 3São Paulo State University (Unesp), Medical School, Department of Surgery, Botucatu, Brazil

N15: Microscopic colitis in two DGH, is there a clear pathway to diagnosis or treatment

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Avery*1, R. Campbell2

1Dorset County Hospital Foundation Trust, Gastroenterology, Dorchester, UK, 2Stepping Hill Hospital, Gastroenterology, Stockport, UK

N16: The influence of children's inflammatory bowel disease (IBD) on the relationship between parents and their married life

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Kotkowicz-Szczur*1, J. Kierkuś2, M. Matuszczyk2

1The Children’s Memorial Health Institute, Department of Gastroenterology, Hepatology and Immunology, Warszawa, Poland, 2Children's Memorial Health Institute, 1Department of Gastroenterology, Hepatology, Feeding disorders and Pediatrics, Warszawa, Poland

N17: Frequency of infliximab-induced skin lesions and their impact on quality of life in inflammatory bowel disease patients treated with infliximab

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Bobnar Sekulic*1, T. Polanc1, U. Koren2, T. Kurent1, N. Smrekar1, J. Hanžel1, D. Drobne1, G. Novak1

1University Medical Centre, Clinical Department of Gastroenterology, Ljubljana, Slovenia, 2University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia

N18: Mood disorders in a IBD population: a single-centre cohort

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Lorenzon*1, A. Dessì1, C. Marinelli1, A. Rigo1, S. Facchin1, M. Inferrera1, R. D'Incà1, B. Barberio1, E. V. Savarino1, F. Zingone1

1Azienda Ospedaliera di Padova, Padova, Italy

N19: Validity of a Korean Version of inflammatory bowel disease–fatigue scale

ECCO '19 Copenhagen

Year: 2019
Authors:

S. H. Lee1, E. S. Kim2, H. D. Kim*3

1Kyungpook National University, College of Nursing, Daegu, South Korea, 2Kyungpook National University Hospital, Division of Gastroenterology, Department of Internal Medicine, Daegu, South Korea, 3Keimyung College University, Department of Nursing, Daegu, South Korea

Files: 1
N20: Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Sider*1, L. Cococcioni1, A. ElZein1, S. Chadokufa1, R. Buckingham1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

1Great Ormond Street Hospital, London, UK

Files: 1
N21: The interpretation of thiopurine metabolites in clinical practice: IBD nurses experience in three North West England NHS trusts

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Campbell*1, E. Nelson2, S. Kari2, J. Hocking3, T. Hickey3

1Stockport Foundation NHS Trust, Gastroenterology, Stockport, UK, 2Macclesfield District General Hospital, Gastroenterology, Macclesfield, UK, 3Royal Blackburn Hospital, Gastroenterology, Blackburn, UK

Files: 1
N22: Audit into initial response to vedolizumab infusions for IBD

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Lloyd-Ford*1, M. Gordon1

1Aneurin Bevan University Health Board, Gastroenterology Ambulatory Unit, Newport, UK

N23: IBD patients experience of the care given at the Stockholm Gastro Centre

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Jäghult*1,2, S. Soto Villagran2, S. Pengel2, L. Niculae2

1Karolinska Institutet Danderyd Hospital, Department of Clinicla Science, Stockholm, Sweden, 2GHP Stockholm Gastro Center, Stockholm, Sweden

Files: 1
N24: Experience with Ustekinumab (STELARA®) in Paediatric inflammatory bowel disease (pIBD) – A case series

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Buckingham*1, S. Sider1, L. Cococcioni1, A. ElZein1, S. Chadokufa1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

1Great Ormond Street Hospital, Gastroenterology, London, UK

Files: 1
OP01: In-depth characterisation of host genetics and gut microbiome unravels novel host–microbiome interactions in inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Hu*1, A. Vich Vila1, R. Gacesa1, V. Collij1, R. Xavier2, C. Stevens3, M. Daly3, C. Wijmenga4, H. van Dullemen1, G. Dijkstra1, M. Visschedijk1, E. Festen1, J. Fu5, A. Kurilshikov4, A. Zhernakova4, R. Weersma1

1Universitair Medisch Centrum Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands, 2Massachusetts General Hospital, Molecular Biology, Boston, MA, USA, 3Broad Institute, Boston, MA, USA, 4Universitair Medisch Centrum Groningen, Genetics, Groningen, The Netherlands, 5Universitair Medisch Centrum Groningen, Pediatrics, Groningen, The Netherlands

OP02: The role of PTPN2 SNP in the pathogenesis of fibrosis in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Li*1, J. Kuemmerle1

1Virginia Commonwealth University, Internal Medicine, Richmond, VA, USA

OP03: Inhibition of autophagy exacerbates intestinal fibrosis and EMT

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Cosin-Roger*1,2, D. Ortiz-Masia3, F. Canet1, A. Trescoli-Garcia1, S. Calatayud1, M. D. Barrachina1

1University of Valencia, Pharmacology, Valencia, Spain, 2Hospital Dr Peset, Valencia, Spain, 3University of Valencia, Medicine, Valencia, Spain

OP04: Turning sweet in inflammatory bowel disease: glycans as novel immunomodulators of T-cell-mediated immune response

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Dias1, M. Pereira1, A. Correia1, I. Alves1, V. Pinto1, L. Azevedo2, L. Maia3, R. Marcos-Pinto3, M. Vilanova1, P. Lago3, S. Pinho*1

1Institute for Research and Innovation in Health (i3S), Immunology, Cancer and GlycoMedicine, Porto, Portugal, 2Medical Faculty, Department of Community Medicine, Information and Health Decision Sciences, Porto, Portugal, 3Porto Centre Hospital, Gastroenterology, Porto, Portugal

OP05: Crohn’s disease exclusion diet is equally effective but better tolerated than exclusive enteral nutrition for induction of remission in mild-to-moderate active paediatric Crohn’s disease: a prospective randomised controlled trial

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Van Limbergen1,2, E. Wine3, A. Assa4, R. Sigall Boneh5, R. Shaoul6, M. Kori7, S. Cohen8, S. Peleg9, H. Shamaly10, A. On11, P. Milman12, L. Abramas5, T. Ziv Baran13, S. Grant14, A. Levine*5,13

1Dalhousie University, Halifax, Canada, 2IWK Center, Halifax, Canada, 3University Alberta, Edmonton, Canada, 4Schneider Medical Center, Petach Tikva, Israel, 5Wolfson Medical Center, Holon, Israel, 6Meyer Hospital, Haifa, Israel, 7Kaplan Hospital, Rehovot, Israel, 8Dana Childrens Hospital, Tel Aviv, Israel, 9HaEmek Hospital, Afula, Israel, 10French Hospital, Nazareth, Israel, 11Poriah Hospital, Tiberias, Israel, 12Hadassah Hospital, Jerusalem, Israel, 13Tel Aviv University, Tel Aviv, Israel, 14Mount Saint Vincent University, Halifax, Canada

OP06: Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression

ECCO '19 Copenhagen

Year: 2019
Authors:

F. Humbel1, P. Juillerat2, M. Scharl1, B. Misselwitz2, P. Schreiner1, A. Macpherson2, G. Rogler1, R. von Känel3, B. Yilmaz4, L. Biedermann*1

1University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland, 2Bern University Hospital, Department of Visceral Surgery and Medicine Bern, Switzerland, 3University Hospital Zurich, Consultation-Liaison Psychiatry and Psychosomatic Medicine, Zurich, Switzerland, 4University of Bern, Maurice Müller Laboratories, Bern, Switzerland

OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairment

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Gul1, E. Jones1,2, Z. Matthews3, P. Sudhakar1,2,4, A. Treveil1,2, D. Divekar2,3, J. Buck3, M. Jefferson3, S. Armstrong5, A. Watson2,3, S. Carding2,3, U. Mayer6, P. Powell3, I. Hautefort1, T. Wileman2,3, T. Korcsmaros*1,2

1Earlham Institute, Norwich, UK, 2Quadram Institute, Norwich, UK, 3Norwich Medical School, University of East Anglia, Norwich, UK, 4KU Leuven, Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium, 5University of Liverpool, National Institute of Health Research, Liverpool, UK, 6School of Biological Sciences, University of East Anglia, Norwich, UK

Page: () 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 182 ()